Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 Jul:83:217-225.
doi: 10.1016/j.cyto.2016.05.003. Epub 2016 May 9.

Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies

Affiliations
Clinical Trial

Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies

Jill Koshiol et al. Cytokine. 2016 Jul.

Abstract

Most gallbladder cancer (GBC) cases arise in the context of gallstones, which cause inflammation, but few gallstone patients develop GBC. We explored inflammation/immune-related markers measured in bile and serum in GBC cases compared to gallstone patients to better understand how inflammatory patterns in these two conditions differ. We measured 65 immune-related markers in serum and bile from 41 GBC cases and 127 gallstone patients from Shanghai, China, and calculated age- and sex-adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) for GBC versus gallstones. We then focused on the markers that were significantly elevated in bile and serum to replicate the findings in serum from 35 GBC cases and 31 gallstone controls from Chile. Comparing the highest versus lowest quantile, 15 markers (23%) were elevated in both serum and bile from GBC versus gallstone patients in the Shanghai study (p<0.05). The strongest OR was for CXCL8 (interleukin-8) in serum (96.8, 95% CI: 11.9-790.2). Of these 15 markers, 6 were also significantly elevated in serum from Chile (CCL20, C-reactive protein, CXCL8, CXCL10, resistin, serum amyloid A). Pooled ORs from Shanghai and Chile for these 6 markers ranged from 7.2 (95% CI: 2.8-18.4) for CXCL10 to 58.2 (95% CI: 12.4-273.0) for CXCL8. GBC is associated with inflammation above and beyond that generated by gallstones alone. This local inflammatory process is reflected systemically. Future longitudinal studies are needed to identify the key players in cancer development, which may guide translational efforts to identify individuals at high risk of developing GBC.

Keywords: Gallbladder cancer; Local inflammation; Systemic inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Association of high versus low immune-related marker category in bile (black circles) and serum (white circles) from gallbladder cancer cases compared to gallstone patients in the Shanghai Biliary Tract Cancer Case-control Study.
Figure 2
Figure 2
Association of high versus low circulating immune-related marker category with gallbladder cancer versus gallstones in the Shanghai Biliary Tract Cancer Case-control Study (black circles) and the Chile Gallbladder Cancer Study (white circles).

Similar articles

Cited by

References

    1. Castro FA, Koshiol J, Hsing AW, Devesa SS. Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J Cancer. 2013;133:1664–71. - PMC - PubMed
    1. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146–59. - PubMed
    1. Bertran E, Heise K, Andia ME, Ferreccio C. Gallbladder cancer: incidence and survival in a high-risk area of Chile. Int J Cancer. 2010;127:2446–54. - PubMed
    1. Key C, Meisner ALW. Cancers of the Liver and Biliary Tract. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988–2001, Patient and Tumor Characteristics. Bethesda: NIH; 2007.
    1. Nogueira L, Freedman ND, Engels EA, Warren JL, Castro F, Koshiol J. Gallstones, cholecystectomy, and risk of digestive system cancers. American journal of epidemiology. 2014;179:731–9. - PMC - PubMed